Abstract:Cell-intrinsic reporters such as luciferase (LUC) and red fluorescent protein (RFP) have been commonly utilized in preclinical studies to image tumor growth and to monitor therapeutic responses. While extrinsic reporters that emit near infrared I (NIR-I: 650-950 nm) or near-infrared II (NIR-II: 1000 -1700 nm) optical signals have enabled minimization of tissue autofluorescence and light scattering, it has remained unclear as to whether their use has afforded more accurate tumor imaging in small animals. Here, we developed a novel optical imaging construct comprised of rare earth lanthanide nanoparticles coated with biodegradable diblock copolymers and doped with organic fluorophores, generating NIR-I and NIR-II emissive bands upon optical excitation. Simultaneous injection of multiple spectrally-unique nanoparticles into mice bearing tumor implants established via intraperitoneal dissemination of LUC+/ RFP+ OVCAR-8 ovarian cancer cells enabled direct comparisons of imaging with extrinsic vs. intrinsic reporters, NIR-II vs. NIR-I signals, as well as targeted vs. untargeted exogenous contrast agents in the same animal and over time. We discovered that in vivo optical imaging at NIR-II wavelengths facilitates more accurate detection of smaller and earlier tumor deposits, offering enhanced sensitivity, improved spatial contrast, and increased depths of tissue penetration as compared to imaging with visible or NIR-I fluorescent agents. Our work further highlights the hitherto underappreciated enhancements in tumor accumulation that may be achieved with intraperitoneal as opposed to intravenous administration of nanoparticles. Lastly, we found discrepancies in the fidelity of tumor uptake that could be obtained by utilizing small molecules for in vivo as opposed to in vitro targeting of nanoparticles to disseminated tumors. (C) 2017 Elsevier Ltd. All rights reserved.

In vivo Photoacoustic Imaging of Tumor Using Gold Nanoparticles as Contrast Agent

Gold Nanoparticles As Contrast Agent for in Vivo Photoacoustic Tomography of Tumor

Early Tumor Detection Afforded by in Vivo Imaging of Near-Infrared Ii Fluorescence

Gold nanoprisms as optoacoustic signal nanoamplifiers for in vivo bioimaging of gastrointestinal cancers.

Gold Nanoshell-Based Photoacoustic Imaging Application in Biomedicine

Gold Nanoprisms As a Hybrid in Vivo Cancer Theranostic Platform for in Situ Photoacoustic Imaging, Angiography, and Localized Hyperthermia

Characterization of the In-Vivo Uptake of Novel Contrast Agents Using Photoacoustic Radiofrequency Spectra

Combining X-Ray and Photoacoustics for in Vivo Tumor Imaging with Gold Nanorods

In Vivo Quantitative Photoacoustic Microscopy of Gold Nanostar Kinetics in Mouse Organs.

Gold nanoflowers for 3D volumetric molecular imaging of tumors by photoacoustic tomography

Imaging-guided High-Efficient Photoacoustic Tumor Therapy with Targeting Gold Nanorods.

In Vivo Photoacoustic Therapy with Cancer-Targeted Indocyanine Green-Containing Nanoparticles.

Antibiofouling Polymer Coated Gold Nanoparticles As A Dual Modal Contrast Agent for X-Ray and Photoacoustic Imaging

In Vivo Photoacoustic Molecular Imaging with Targeting Single-Walled Carbon Nanotubes

Effects Of Photoacoustic Imaging And Photothermal Ablation Therapy Mediated By Targeted Hollow Gold Nanospheres In An Orthotopic Mouse Xenograft Model Of Glioma

Palladium Nanosheets As Highly Stable and Effective Contrast Agents for in Vivo Photoacoustic Molecular Imaging

Thin Layer-Protected Gold Nanoparticles for Targeted Multimodal Imaging with Photoacoustic and CT

In Vivo Photoacoustic Molecular Imaging of Breast Carcinoma with Folate Receptor-Targeted Indocyanine Green Nanoprobes

In Vivo Self-Bio-imaging of Tumors Through in Situ Biosynthesized Fluorescent Gold Nanoclusters.

Photoacoustic Imaging of Hepatocellular Carcinoma Targeting Gold Nanoshells (conference Presentation)

In Vitro Study of PLGA/PFH Particles Loaded with Gold Nanoparticles As Theranostic Agents for Photoacoustic Imaging and Cancer Therapy